Prabesh Kanel — Biomedical Watch V2

Traitements2programmes

Essais1liés

Publications0liées

SourceDBlocale

Traitements

2

Molécule	Indication / population	Phase	Objectif	Pays	Résultat
TributyrinThis research is studying a supplement called tributyrin in people with Progressive Supranuclear Palsy (PSP) to learn about its safety and tolerability as a potential treatment. The goal of this research study is to see if a similar supplementation regimen and virtual testing is feasible for people with PSP.	Parkinson	Phase 1/2	À vérifier	United States	À vérifier
TributyrinThis research is studying a supplement called tributyrin in people with Progressive Supranuclear Palsy (PSP) to learn about its safety and tolerability as a potential treatment. The goal of this research study is to see if a similar supplementation regimen and virtual testing is feasible for people with PSP.	Parkinson	Phase 1/2	À vérifier	United States	À vérifier

Essais cliniques

1

Molécule	Indication / population	Phase	NCT	Titre	Statut
Tributyrin	Parkinson	Phase 1/2	NCT07863180	BUTTER2 — Tributyrin for Progressive Supranuclear Palsy (PSP): Virtual Trial	RECRUITING

Publications

0

Molécule	Indication / population	Titre	Journal	Date
Aucune publication.